<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A male with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) following <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> is reported </plain></SENT>
<SENT sid="1" pm="."><plain>The patient had been diagnosed as <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> at 8 years of age, and treated with blood transfusions, anabolic and <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> steroid hormones </plain></SENT>
<SENT sid="2" pm="."><plain>Over a period of subsequent twelve years, he had remission and deterioration </plain></SENT>
<SENT sid="3" pm="."><plain>At the age of 21, the patient developed a sudden progression of severe <z:hpo ids='HP_0001903'>anemia</z:hpo>, when his bone marrow showed <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> with prominent dyshematopoiesis and excess of blasts, compatible with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> by the definition of FAB classification </plain></SENT>
<SENT sid="4" pm="."><plain>He received low dose Ara-C therapy, which was ineffective </plain></SENT>
<SENT sid="5" pm="."><plain>Nine months later he developed <z:hpo ids='HP_0004845'>acute monocytic leukemia</z:hpo> (M5b) and died </plain></SENT>
<SENT sid="6" pm="."><plain>Chromosomal analysis revealed 46, XY at the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, 46, XY, del (6) (q21 q27) at the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and 46, XY, -7, +21, 6q-/47, XY, +Y, -7, +21, 6q- at the <z:hpo ids='HP_0011009'>acute</z:hpo> leukemic stage </plain></SENT>
</text></document>